Onc Now: A Career at the Cutting Edge of Nuclear Medicine

Nuclear medicine has undergone extraordinary transformation over the past decades, and it continues to redefine how cancer is diagnosed and treated. In this episode, Ken Herrmann reflects on his journey into nuclear medicine, the rapid evolution from PET to PET-CT, and the rise of theranostics. He discusses the balance between innovation and evidence, the growing role of multidisciplinary cancer care, and what lies ahead for the field, including the potential impact of AI. This is a forward-looking conversation for clinicians and researchers at every stage of their career.

Timestamps:

00:00 – Introduction

01:07 – His journey into nuclear medicine

02:45 – Impact of nuclear medicine

03:49 – The evolution of his research

05:22 – Theranostics

06:35 – What is the next breakthrough?

08:20 – Balancing innovation with evidence-based practice

09:45 – Multidisciplinary cancer care

11:30 – Biggest challenges in nuclear medicine

13:42 – Future of nuclear medicine

14:58 – Advice to early-career clinicians

16:00 – The potential of AI

17:57 – Three magic wishes for healthcare